Form 8-K - Current report:
SEC Accession No. 0001437749-25-011690
Filing Date
2025-04-10
Accepted
2025-04-10 17:03:15
Documents
15
Period of Report
2025-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250410_8k.htm   iXBRL 8-K 30424
2 EXHIBIT 4.1 ex_800578.htm EX-4.1 124392
  Complete submission text file 0001437749-25-011690.txt   325771

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wint-20250404.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250404_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250404_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250404_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT wint20250410_8k_htm.xml XML 2849
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25829123
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)